December 7, 2010 (San Jose, California) — A new study examining the prevalence of different hepatitis B virus (HBV) genotypes in a database of approximately 2400 specimens showed approximately equal ...

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...

Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS, Oct. 11, 2022 /PRNewswire/ -- ...

Oncolytic viruses, including the measles virus (MeV), exhibit a preferential ability to kill cancer cells, making them promising candidates for novel tumor therapies. As part of their infection cycle, ...

Brown joined Charles River in November 2022 after completing his bachelor’s degree from the University of Scranton. Brown started his journey in the Viral Clearance Department at the Wayne, PA site as ...

Quantification of empty and full adeno-associated virus (AAV) capsids is crucial for maximizing viral vectors used in gene therapy. The launch of the Vericheck ddPCR Empty-Full Capsid Kit expands this ...

Asimov launched its AAV Edge Stable Producer system with the goal of addressing the shortcomings of traditional transient transfection-based production and bringing AAV manufacturing standards closer ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...